Treating adult acne without inducing xerosis (dryness) requires a 'low and slow' approach that prioritises barrier integrity. The best strategy involves utilising lipophilic actives like salicylic acid or retinoids, but pairing them with humectants and physiological lipids. Specifically, opting for encapsulated retinol or adapalene can provide the necessary comedolytic activity with a lower risk of transepidermal water loss (TEWL) compared to traditional tretinoin [1]. By incorporating these actives into a routine that features niacinamide, you can enhance the skin's natural production of ceramides, which helps to mitigate the irritation often associated with acne medications [2].
Furthermore, the best results are often achieved through 'short-contact therapy' or the 'sandwich method'. The sandwich method involves applying a thin layer of moisturiser both before and after a retinoid, which slows the penetration of the active ingredient and reduces potential irritation without negating its long-term efficacy [3]. Additionally, swapping harsh, foaming surfactants for non-comedogenic cream cleansers ensures that the acid mantle remains intact, preventing the 'tight' feeling often felt after washing. This method addresses the underlying pilosebaceous unit dysfunction while ensuring the stratum corneum remains hydrated and resilient [4].
Adult acne, particularly in women, is clinically distinct from adolescent acne. It is often characterised by inflammatory lesions located primarily along the U-zone (jawline and chin) and is frequently associated with a compromised skin barrier and increased sensitivity [1]. Unlike teenage skin, which often exhibits high sebum production, adult skin undergoes a natural decline in lipid production and cellular turnover, making it more prone to dehydration when exposed to traditional anti-acne agents like benzoyl peroxide [5].
From a biochemical perspective, the goal is to manage Cutibacterium acnes proliferation and hyperkeratinisation while maintaining the lipid bilayer. Research indicates that inflammatory pathways in adult acne are highly sensitive to oxidative stress, meaning that the addition of antioxidants and anti-inflammatory agents can actually improve acne outcomes more effectively than aggressive exfoliation [2]. Supporting the skin's microbiome through pH-balanced formulations is essential to prevent secondary infections and chronic inflammation [4].
For those seeking a clarified complexion without compromising their moisture barrier, our Surface Purify cleanser was formulated with salicylic acid and bakuchiol to address congestion while maintaining essential hydration. To further support a balanced skin microbiome during treatment, some of our customers find that following with Balance Biome Crème helps to reinforce the skin’s natural defence and prevent the dryness often associated with active ingredients.
FAQ
Which active ingredients are best for hydrating acne-prone skin?
Niacinamide (Vitamin B3) is a premier choice as it regulates sebum while stimulating ceramide synthesis to strengthen the barrier [2]. Additionally, azelaic acid is highly effective for adult acne due to its anti-inflammatory and antimicrobial properties, yet it is significantly less drying than benzoyl peroxide or high-strength retinoids [3].
Can I use facial oils if I have adult acne?
Yes, provided they are high in linoleic acid. Adult acne patients often have sebum deficient in linoleic acid, which contributes to clogged pores. Oils like rosehip or hemp seed can help balance the sebum profile without being comedogenic, though they should be applied over a water-based moisturiser to lock in hydration [4][5].
How does the Australian climate affect adult acne treatment?
The high UV index in Australia can exacerbate post-inflammatory hyperpigmentation (PIH) and further dehydrate the skin. Using a broad-spectrum SPF 50+ is non-negotiable when using acne treatments, as many actives increase photosensitivity. Modern Australian formulations often include 'dry touch' technology to provide protection without clogging pores [1][6].
References:
[1] Zeichner JA, et al. Journal of Clinical and Aesthetic Dermatology. 2018;11(1):21-27.
[2] Draelos ZD, et al. Dermatologic Therapy. 2021;34(2):e14757. doi:10.1111/dth.14757.
[3] Berson DS, et al. Journal of Drugs in Dermatology. 2013;12(3):s12-s16.
[4] Del Rosso JQ. The Journal of Clinical and Aesthetic Dermatology. 2013;6(2):19-24.
[5] Downing DT, et al. Journal of Investigative Dermatology. 1986;86(4):453-456.
[6] Passeron T, et al. Journal of the European Academy of Dermatology and Venereology. 2019;33(S7):5-19. doi:10.1111/jdv.15779.
